03:19 PM EST - Microbix Biosystems Inc. : Announced plans to develop and introduce new products for use in diagnostic tests and vaccine research in response to the emergent Zika virus, which is spreading throughout the Americas and is being characterized as a crisis by health authorities. Microbix Biosystems Inc.
shares T.MBX are trading up $0.025 at $0.30.
